期刊文献+

洛阳地区献血员人类血小板抗原1~10频率分布调查 被引量:1

Investigation of frequency distribution of human platelet antigen-1to-10 in Luoyang
原文传递
导出
摘要 目的:研究洛阳地区献血员人类血小板抗原(HPA)1~10基因多态性,为患者提供HPA相配合的血小板。方法:随机收集250例无偿献血员样本,应用聚合酶链式反应一序列特异引物(PCR—SSP)技术检测HPA-1~10基因型及等位基因频率。结果:HPA-1aa、-1ab所占百分比分别为98.80%和1.20%,HPA-2aa、-2ab所占百分比分别为90.80%和9.20%,HPA-4aa、-4ab所占百分比分别为98.00%和2.00%,HPA-5aa、-5ab所占百分比分别为96.40%和3.60%,HPA-aa、-ab、-bb三种基因型在HPA-3和HPA-6中的比例分别为29.20%、46.00%、24.80%和91.60%、6.80%、1.60%,在HPA7、-8、-9、10中仅检测到HPA—aa纯合子。结论:洛阳地区HPA-1~HPA-10基因分布与文献报道相似,HPA-3特异性抗体是引起本地区HPA同种免疫性疾病的首要原因。 Objective:To study the gene polymorphism of human platelet antigen(HPA) -1 to 10,in order to provide patients with the HPA compatible platelets. Method:A total of 250 samples were collected from the blood donors randomly, and the genotypes and allele frequencies of HPA-1 to 10 were detected by polymerase chain reac- tion sequence specific primers (PCR-SSP). Result:The percentages of HPA-laa and-lab were 98.80% and 1.20% respectively. The percentages of HPA-2aa and-2ab were 90.80% and 9.20% respectively. The percentages of HPA-4aa and-4ab were 98.00% and 2.00% respectively. The percentages of HPA-5aa and 5ab were 96. 40% and 3.60% respectively. The proportions of HPA aa,-ab and-hb in HPA-3 and HPA-6 were 29.20%, 46.00%, 24.80 % and 91.60 %, 6.80 %, 1.60 % respectively. The HPA-aa homozygous only was detected out in HPA-7 ,- 8,-9 ,-10. Conclusion: The gene distributions of HPA-1 to HPA-10 was similar to those reported in the literature. The HPA-3 specific antibody was the major cause for HPA autoimmune diseases in Luoyang.
机构地区 洛阳市中心血站
出处 《临床血液学杂志(输血与检验)》 CAS 2014年第3期464-467,共4页 Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)
关键词 人类血小板抗原 基因 血型 PCR—SSP human platelet antigem gene blood group PCR-SSP
  • 相关文献

参考文献8

  • 1张冬霞.吉林地区汉族人群血小板抗原系统基因分型研究[J].中国输血杂志,2011,24(10):869-870. 被引量:10
  • 2周琼秀,李执如,陈静娴.PCR-SSP在人类血小板抗原1—6、15系统基因分型中的应用[J].中国输血杂志,2009,22(4):288-289. 被引量:3
  • 3MCYEY M, CSERTI-GAZDEWICH C M. Platelet transfusion refractoriness responding preferentially to single donor aphaeresis platelet compatible for both ABOand HLA[J]. Transfus Med. 2010, 20: 346- 353.
  • 4XIA W J, YE X, TIAN L W,et aI. Establishment of platelet donor registry improves the treatment of piatelet transfusion refractoriness in Guangzhou region of China[J]. Transfus Med, 2010, 20:269-274.
  • 5FENG M L, LIU D Z, SHEN W, et al. Establish- ment of an HPA-1- to -16-typed platelet donor regis- try in China[J]. Transfus Med, 2006,16:369- 374.
  • 6COLLINS C L, SCOTT J P, PANEPINTO J A, et al. Severe thrombocytopenia in a child secondary to passive platelet antibody transfer from a plasma trans fusion[J]. J Pediatr Hematol Oncol, 2013,35:226 - 228.
  • 7SHEHATA N, DENOMME G A, HANNACH B, et al. Mass-scale high-throughput multiplex polymerase chain reaction for human platelet antigen single-nucle- otide polymorphisms screening of apheresis platelet donors[J]. Transfusion, 2011,51 : 2028- 2033.
  • 8BHATTI F A, UDDIN M, AHMED A, et al. Hu- man platelet antigen polymorphisms (HPA-1, -2, -3, -4, -5 and -15) in major ethnic groups of Pakistan[J]. Transfus Med, 2010,20: 78- 87.

二级参考文献8

共引文献11

同被引文献38

  • 1胡丽华.检验与临床诊断分析[M].北京:人民军医出版社,2009:60-62.
  • 2曹斯,张学元.广州首现CD36抗体引起血小板输注无效病例[N].南方日报,2011-7-19(A09).
  • 3夏文杰.血小板输血与血小板输注无效[A].魏亚明,吕毅,主编.基础输血学[M].北京:人民卫生出版社,2011:275-280.
  • 4De Gaetano G. Historical over of the platelets in hemostasis and thrombosis [J]. Haematologica, 2001, 86(4): 349-356.
  • 5Hod E, Schwartz. Platelet transfusion refractoriness[J]. BrHaematol, 2008,142 (3): 348-360.
  • 6Rebulla P. Formulae for the definition of refractoriness to platelet transfusion[J]. Transfusion medicine, 1993, 3(1): 91-93.
  • 7Vassallo RR. Recognition and management of antibodies to human plateletantigens in platelet transfusion- refractory patients[J]. Irnmunohematology, 2009, 25(3): 119-124.
  • 8Petz DL, Garratty G. Selecting donors of platelets for refractorypatientson the basis of HLA antibody specificity[J]. Transfusion, 2000, 40(12) :1446-1456.
  • 9Ogata T. CD36 (Naka) sensitization with platelet- transfusion refractoriness in a liver transplant recipient[J]. Transplantation, 2005, 79(5) : 620.
  • 10Eisenberg S. Refractory response to platelet transfusion therapy[J]. J Infus Nurs, 2010, 33(2): 89-97.

引证文献1

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部